1
|
Decaudin D. Clinicopathologic features and treatment options of ocular adnexal lymphoma. EXPERT REVIEW OF OPHTHALMOLOGY 2010. [DOI: 10.1586/eop.10.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
2
|
Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LLL. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 2006; 108:1451-60. [PMID: 16638927 DOI: 10.1182/blood-2006-02-005017] [Citation(s) in RCA: 115] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
The recent literature shows that interest in ocular adnexal lymphomas and their biologic and clinical characteristics—along with their possible association with Chlamydia psittaci infection and therapeutic management with rituximab or anti-Chlamydia psittaci antibiotic therapy—is considerable. These new data have modified the previously reported features of this disease and have made an updated review of the literature necessary. The aims of this review are to present the current knowledge on the biology of these lymphomas, their clinical features and prognostic factors, and the panel of all available treatment options.
Collapse
Affiliation(s)
- Didier Decaudin
- Service d'Hématologie, Institut Curie, 26 rue d'Ulm, 75.248 Paris cedex 05, France.
| | | | | | | | | |
Collapse
|